Human prothrombin complex (Nanyue Biopharming)

人凝血酶原复合物（南岳生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Nanyue Biopharming)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2019/09/05
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksN/A